Implementation science in cancer prevention and control: A framework for research and programs in low- And middle-income countries

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 11, 2014, Pages 2273-2284

  Sivaram, Sudha ^a   Sanchez, Michael A ^a   Rimer, Barbara K ^b   Samet, Jonathan M ^c   Glasgow, Russell E ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR MODIFICATION; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RESEARCH; CANCER RISK; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CULTURAL FACTOR; DIET; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; IMPLEMENTATION SCIENCE; LIFESTYLE MODIFICATION; LOW MIDDLE INCOME COUNTRY; LOWEST INCOME GROUP; OBESITY; PHYSICAL ACTIVITY; PROGRAM EVALUATION; RISK FACTOR; SOCIAL ASPECT; DEVELOPING COUNTRY; EARLY CANCER DIAGNOSIS; ECONOMICS; EVIDENCE BASED MEDICINE; HEALTH EDUCATION; HEALTH SERVICES RESEARCH; NEOPLASMS; ORGANIZATION AND MANAGEMENT; PROCEDURES; PROGRAM DEVELOPMENT;

DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; EVIDENCE-BASED MEDICINE; HEALTH EDUCATION; HEALTH PLAN IMPLEMENTATION; HEALTH SERVICES RESEARCH; HUMANS; NEOPLASMS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; RISK FACTORS;

EID: 84920162557     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0472     Document Type: Article

References (86)

1. Globocan. Estimated cancer incidence, mortality, and prevalence worldwide in 2012; 2012 [cited 2013 Dec 20]. Available from: http://globocan.iarc.fr/Pages/fact-sheets-cancer.aspx.
2. Parkin DM, Bray F. Chapter 2: the burden of HPV-related cancers. Vaccine 2006;24:S3/11-25.
3. Varmus H, Kumar HS. Addressing the growing international challenge of cancer: a multinational perspective. Sci Trans Med 2013;5:175cm2.
4. Disease GBo. [cited 2014 Jan 15]. Available from: http://viz.healthmetricsandevaluation. org/gbd-compare/.
5. Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010;376:1186-93.
6. Remme JH, Adam T, Becerra-Posada F, D'Arcangues C, Devlin M, Gardner C, et al. Defining research to improve health systems. PLoS Med 2010;7:e1001000.
7. National Cancer Institute. Cancer control framework synthesis and rationale; [cited 2014 Jan 16]. Available from: http://cancercontrol.cancer.gov/od/about.html.
8. Mwanahamuntu MH, Sahasrabuddhe VV, Kapambwe S, Pfaendler KS, Chibwesha C, Mkumba G, et al. Advancing cervical cancer prevention initiatives in resource-constrained settings: insights from the Cervical Cancer Prevention Program in Zambia. PLoS Med 2011;8:e1001032.
9. Pan American Health Organization. Cervical cancer prevention and control programs:Arapid assessment in 12 countries of Latin America. Washington, DC: PAHO; 2010.
10. Knaul FM, Gonzalez-Pier E, Gomez-Dantes O, Garcia-Junco D, Arreola-Ornelas H, Barraza-Llorens M, et al. The quest for universal health coverage: achieving social protection for all in Mexico. Lancet 2012;380:1259-79.
11. Tamil Nadu Health Systems Project T; [cited 2013 November 1]. Available from: http://www.tnhsp.org/project/project-components.
12. Morhason-Bello IO, Odedina F, Rebbeck TR, Harford J, Dangou JM, Denny L, et al. Challenges and opportunities in cancer control in Africa: a perspective from the African Organisation for Research and Training in Cancer. Lancet Oncol 2013;14:e142-51.
13. Di Cesare M, Khang YH, Asaria P, Blakely T, Cowan MJ, Farzadfar F, et al. Inequalities in non-communicable diseases and effective responses. Lancet 2013;381:585-97.
14. Pedraza AM, Pollan M, Pastor-Barriuso R, Cabanes A. Disparities in breast cancer mortality trends in a middle income country. Breast Cancer Res Treat 2012;134:1199-207.
15. WHO.Tobacco Fact Sheet:No339 2013; [cited 2013 Jun 10]. Available from: http://www.who.int/mediacentre/factsheets/fs339/en.
16. Kids TF. Indonesia: Tobacco burden facts; 2013. Available from: http://global.tobaccofreekids.org/files/pdfs/en/Indonesia-tob-burden-en.pdf.
17. Zhang J, Ou JX, Bai CX. Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology 2011; 16:1165-72.
18. WHO. 90% of smokeless tobacco users live in South-east Asia; 2013 [cited 2014 Feb 16]. Available from: http://www.searo.who.int/mediacentre/ releases/2013/pr1563/en/index.html.
19. Arora M, Madhu R. Banning smokeless tobacco in India: policy analysis. Indian J Cancer 2012;49:336-41.
20. Sridharan G. Epidemiology, control and prevention of tobacco induced oral mucosal lesions in India. Indian J Cancer 2014;51:80-5.
21. WHO. MPOWER in action: defeating the global tobacco epidemic; Available from: http://www.who.int/tobacco/mpower/publications/mpower-2013.pdf. Waggoner S. Cervical cancer Lancet 2003; 361: 2217-2225 Waggoner S. Cervical cancer. Lancet 2003;361:2217-25.
22. Kane MA, Serrano B, de Sanjose S, Wittet S. Implementation of human papillomavirus immunization in the developing world. Vaccine 2012;30 Suppl 5:F192-200.
23. LaMontagne DS, Barge S, Le NT, Mugisha E, Penny ME, Gandhi S, et al. Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries. Bull World Health Organ 2011;89:821-30B.
24. Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. PLoS ONE 2014;9: e90912.
25. Brotherton JM, Murray SL, Hall MA, Andrewartha LK, Banks CA, Meijer D, et al. Human papillomavirus vaccine coverage among female Australian adolescents: success of the school-based approach. Med J Aust 2013;199:614-7.
26. Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F. Achieving high coverage in Rwanda's national human papillomavirus vaccination programme. Bull World Health Organ 2012;90: 623-8.
27. Oluwole D, Kraemer J. Innovative public-private partnership: a diagonal approach to combating women's cancers in Africa. Bull World Health Organ 2013;91:691-6.
28. Girish N, Kavita R, Gururaj G, Benegal V. Alcohol use and implications for public health: patterns of use in four communities. Indian J Community Med 2010;35:238-44.
29. WHO. Global status report on alcohol and health, 2011; 2011. Available from: http://www.who.int/substance-abuse/publications/global-alcohol-report/msbgsruprofiles.pdf.
30. Muwonge R,Ramadas K, Sankila R, Thara S,Thomas G, Vinoda J, et al. Role of tobacco smoking, chewing and alcohol drinking in the risk of oral cancer in Trivandrum, India: a nested case-control design using incident cancer cases. Oral Oncol 2008;44:446-54.
31. Prabhu A, Obi KO, Rubenstein JH. The synergistic effects of alcohol and tobacco consumption on the risk of esophageal squamous cell carcinoma: a meta-analysis. Am J Gastroenterol 2014;109: 822-7.
32. Benegal V. India: alcohol and public health. Addiction 2005;100: 1051-6.
33. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014;384:766-81.
34. Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev 2012;70:3-21.
35. Popkin B, Monteiro C, Swinburn B. Overview: Bellagio Conference on Program and policy options for preventing obesity in the lowand middle-income countries. Obes Reviews 2013;14 Suppl 2: 1-8.
36. Landrigan PJ, Espina C, Neira M. Global prevention of environmental and occupational cancer. Environ Health Perspect 2011;119:A280-1.
37. Institute for Health Metrics and Evaluation. Global burden of disease cause patterns; 2013. Available from: http://www.healthmetricsandevaluation.org/gbd/visualizations/gbd-cause-patterns.
38. King BA, Mirza SA, Babb SD. A cross-country comparison of secondhand smoke exposure among adults: findings from the Global Adult Tobacco Survey (GATS). Tob Control 2013;22:e5.
39. Knaul FM, Bhadelia A, Gralow J, Arreola-Ornelas H, Langer A, Frenk J. Meeting the emerging challenge of breast and cervical cancer in lowand middle-income countries. Int J Gynaecol Obstet 2012;119 Suppl 1:S85-8.
40. Espina C, Porta M, Schuz J, Aguado IH, Percival RV, Dora C, et al. Environmental and occupational interventions for primary prevention of cancer: a cross-sectorial policy framework. Environ Health Perspect 2013;121:420-6.
41. Denny L, Quinn M, Sankaranarayanan R. Chapter 8: screening for cervical cancer in developing countries. Vaccine 2006;24 Suppl 3:S3/71-7.
42. Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med 2008;5:e132.
43. Shastri SS, Mittra I, Mishra GA, Gupta S, Dikshit R, Singh S, et al. Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. J Natl Cancer Inst 2014;106: dju009.
44. Gravitt PE, Belinson JL, Salmeron J, Shah KV. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer 2011;129:517-27.
45. Sankaranarayanan R, Rajkumar R, Esmy PO, Fayette JM, Shanthakumary S, Frappart L, et al. Effectiveness, safety and acceptability of 'see and treat' with cryotherapy by nurses in a cervical screening study in India. Br J Cancer 2007;96:738-43.
46. Sankaranarayanan R, Rajkumar R, Theresa R, Esmy PO, Mahe C, Bagyalakshmi KR, et al. Initial results from a randomized trial of cervical visual screening in rural south India. Int J Cancer 2004; 109:461-7.
47. Anderson BO, Cazap E, El Saghir NS, Yip CH, Khaled HM, Otero IV, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011;12: 387-98.
48. Anderson BO, Yip CH, Smith RA, Shyyan R, Sener SF, Eniu A, et al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 2008;113(8 Suppl):2221-43.
49. McTiernan A,Porter P, Potter JD. Breast cancer prevention in countries with diverse resources. Cancer 2008;113(8 Suppl):2325-30.
50. Abuidris DO, Elsheikh A, Ali M, Musa H, Elgaili E, Ahmed AO, et al. Breast-cancer screening with trained volunteers in a rural area of Sudan: a pilot study. Lancet Oncol 2013;14:363-70.
51. Ramogola-Masire D, de Klerk R, Monare B, Ratshaa B, Friedman HM, Zetola NM. Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana. J Acquir Immune Defic Syndr 2012;59:308-13.
52. Ginsburg OM, Chowdhury M, Wu W, Chowdhury MT, Pal BC, Hasan R, et al. An mHealth model to increase clinic attendance for breast symptoms in rural Bangladesh: can bridging the digital divide help close the cancer divide? Oncologist 2014;19:177-85.
53. Parashari A, Singh V, Mittal T, Ahmed S, Grewal H, Gupta S, et al. Low cost technology for screening early cancerous lesions of oral cavity in rural settings. Ann Med Health Sci Res 2014;4:146-8.
54. Institute of Medicine. Cancer control opportunities in low- and middle-income countries. Sloan FA, Gellband H, editors. Washington, DC: National Academies Press; 2007.
55. Levin A, Wang SA, Levin C, Tsu V, Hutubessy R. Costs of introducing and delivering HPVvaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries. PLoS ONE 2014;9:e101114.
56. WHO. WHO welcomes new record low price for human papillomavirus (HPV) vaccines 2013 [cited 2014 Jul 11]. Available from: http://www.who.int/immunization/newsroom/press/record-low-price-hpv-vaccines/en/.
57. Society AC. Human Papilloma Virus (HPV), Cancer, HPV testing, and HPV vaccines: frequently asked questions 2014; [cited 2014 Jul 11]. Available from: http://www.cancer.org/cancer/cancercauses/othercarcinogens/infectiousagents/hpv/humanpapillomavirusandhpvvaccinesfaq/hpv-faq-vaccine-cost.
58. WHO. Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy A demonstration project in six African countries: Malawi, Madagascar, Nigeria, Uganda, the United Republic of Tanzania, and Zambia 2012; [cited 2014 Jul 11]. Available from: http://screening.iarc.fr/doc/9789241503860-eng.pdf.
59. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005;353:2158-68.
60. Zelle SG, Baltussen RM. Economic analyses of breast cancer control in low- and middle-income countries: a systematic review. Syst Rev 2013;2:20.
61. Zelle SG, Nyarko KM, Bosu WK, Aikins M, Niens LM, Lauer JA, et al. Costs, effects and cost-effectiveness of breast cancer control in Ghana. Trop Med Int Health 2012;17:1031-43.
62. Glasgow RE, Chambers D. Developing robust, sustainable, implementation systems using rigorous, rapid and relevant science. Clin Transl Sci 2012;5:48-55.
63. Brownson RC, Colditz GA, Proctor EK, editors. Dissemination and implementation research in Health: translating science to practice. New York, NY: Oxford University Press; 2012.
64. Fixsen DN, SF; Blase KA, Friedman RM, Wallace F. Implementation research: a synthesis of the literature. Tampa, FL: University of South Florida; Louis de la Parte Florida Mental Health Institute, The National Implementation Research Network (FMHI Publication #231); 2005.
65. Center FI. Implementation science information and resources 2013. Available from: http://www.fic.nih.gov/researchtopics/pages/implementationscience.aspx.
66. Glasgow RE, Green LW, Taylor MV, Stange KC. An evidence integration triangle for aligning science with policy and practice. Am J Prev Med 2012;42:646-54.
67. Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol 2009;62:464-75.
68. Nallamothu BK, Hayward RA, Bates ER. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation 2008;118:1294-303.
69. WHO. Social determinants of health 2013. Available from: http://www. who.int/social-determinants/en/.
70. WHO. Task shifting: rational distribution of tasks among health workforce teams; 2008.
71. WHO. WHO Framework convention on tobacco control; [cited 2014 Aug 10]. Available from: http://whqlibdoc.who.int/publications/2003/9241591013.pdf?ua=1.
72. Cairney P, Mamudu H. The global tobacco control 'endgame': change the policy environment to implement the FCTC. J Public Health Policy. 2014 May 15. [Epub ahead of print].
73. Jackson DJ, Chopra M, Doherty TM, Colvin MS, Levin JB, Willumsen JF, et al. Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1. AIDS 2007;21:509-16.
74. Painter TM, Diaby KL, Matia DM, Lin LS, Sibailly TS, Kouassims MK, et al. Sociodemographic factors associated with participation by HIV-1-positive pregnant women in an intervention to prevent mother-to-child transmission of HIV in Cote d'Ivoire. Int J STD AIDS 2005;16:237-42.
75. Nobrega I, Netto EM, Brites C. Barriers to prevention of HIV type 1 mother-to-child-transmission in Bahia, Brazil. AIDS Res Hum Retroviruses 2012;28:233-4.
76. Padian NS, Holmes CB, McCoy SI, Lyerla R, Bouey PD, Goosby EP. Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr 2011;56:199-203.
77. Hyun S, Hodorowski JK, Nirenberg A, Perocchia RS, Staats JA, Velez O, et al. Mobile health-based approaches for smoking cessation resources. Oncol Nurs Forum 2013;40:E312-9.
78. Odigie VI, Yusufu LM, Dawotola DA, Ejagwulu F, Abur P, Mai A, et al. The mobile phone as a tool in improving cancer care in Nigeria. Psychooncology 2012;21:332-5.
79. Merriam S, Muhamad M. Roles traditional healers play in cancer treatment in Malaysia: implications for health promotion and education. Asian Pac J Cancer Prev 2013;14:3593-601.
80. PinkRibbonRedribbon. [cited 2013 Dec 1]. Available from: http://pinkribbonredribbon.org/.
81. National Cancer Institute, Center for Global Health. Funding opportunities 2014; [cited 2014 Jan 15]. Available from: http://www.cancer. gov/aboutnci/organization/global-health/funding-and-training/cgh-funding-training.
82. National Cancer Institute. Implementation science: Integrating evidence into research, practice and policy 2014; [cited 2014 Jan 15]. Available from: http://cancercontrol.cancer.gov/is/funding.html.
83. US Centers for Disease Control and Prevention. Global health: noncommunicable disease. Saving Lives through Screening: Cervical Cancer 2014 [cited 2014 Jan 15]. Available from: http://www.cdc. gov/globalhealth/ncd/cervicalcancer.htm.
84. Lamas D, Rosenbaum L. Painful inequities-palliative care in developing countries. N Engl J Med 2012;366:199-201.
85. NIH. U.S.-India Bilateral Collaborative Research Partnerships (CRP) on the Prevention of HIV/AIDS and Co-morbidities; [cited 2014 Jul 9]. Available from: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-033.html.
86. National Institute of Allergy and Infectious Diseases. US-China Cooperative Biomedical Research Program; [cited 2014 Jul 9]. Available from: http://www.niaid.nih.gov/topics/globalresearch/region/eastasiapacific/uschina/Pages/default.aspx.